Menu utilisateur

Accès à distance ? S'identifier sur le proxy UCLouvain

Rechercher

Affichage: 4 résultats.
    • Article de périodique
    Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study.
    Pipe, Steven W Shima, Midori Lehle, Michaela Shapiro, Amy Chebon, Sammy Fukutake, Katsuyuki Key, Nigel S Portron, Agnès Schmitt, Christophe Podolak-Dawidziak, Maria Selak Bienz, Nives Hermans, Cédric[UCL] Campinha-Bacote, Avrita Kiialainen, Anna Peerlinck, Kathelijne Levy, Gallia G Jiménez-Yuste, Victor (2019) The Lancet. Haematology — Vol. 6, no.6, p. e295-e305 (2019)
    • Article de périodique
    Emicizumab use in females with moderate or mild hemophilia A without factor VIII inhibitors who warrant prophylaxis.
    Hermans, Cédric[UCL] Ventriglia, Giuliana Obaji, Samya Beckermann, Benjamin M Lehle, Michaela Catalani, Olivier d'Oiron, Roseline Frenzel, Laurent (2023) Research and practice in thrombosis and haemostasis — Vol. 7, no.8, p. 102239 [1-7] (2023)
    • Article de périodique
    Long-term outcomes with emicizumab in hemophilia A without inhibitors: results from the HAVEN 3 and 4 studies.
    Mahlangu, Johnny Jiménez-Yuste, Víctor Ventriglia, Giuliana Niggli, Markus Barlera, Simona Hermans, Cédric[UCL] Lehle, Michaela Chowdary, Pratima Jew, Lyle Windyga, Jerzy Frenzel, Laurent Schmitt, Christophe Castaman, Giancarlo Pipe, Steven W (2024) Research and practice in thrombosis and haemostasis — Vol. 8, no.2, p. 102364 [1-12] (2024)
    • Article de périodique
    Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study.
    Négrier, Claude Mahlangu, Johnny Lehle, Michaela Chowdary, Pratima Catalani, Olivier Bernardi, Ronald J Jiménez-Yuste, Víctor Beckermann, Benjamin M Schmitt, Christophe Ventriglia, Giuliana Windyga, Jerzy d'Oiron, Roseline Moorehead, Paul Koparkar, Sunita Teodoro, Vanda Shapiro, Amy D Oldenburg, Johannes Hermans, Cédric[UCL] (2023) The Lancet. Haematology — Vol. 10, no.3, p. e168-e177 (2023)